Duckworth David M. 4
4 · Acadia Healthcare Company, Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Duckworth David M.
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-03-11$58.04/sh−18,780$1,089,991→ 71,773 total - Exercise/Conversion
Common Stock
2021-03-11$9.40/sh+875$8,225→ 72,648 total - Exercise/Conversion
Common Stock
2021-03-11$16.60/sh+7,591$126,011→ 81,053 total - Exercise/Conversion
Common Stock
2021-03-11$15.96/sh+814$12,991→ 73,462 total - Exercise/Conversion
Common Stock
2021-03-11$29.39/sh+9,500$279,205→ 90,553 total - Exercise/Conversion
Stock Option
2021-03-11−875→ 0 totalExercise: $9.40From: 2012-11-16Exp: 2021-11-16→ Common Stock (875 underlying) - Exercise/Conversion
Stock Option
2021-03-11−814→ 0 totalExercise: $15.96From: 2013-03-19Exp: 2022-03-19→ Common Stock (814 underlying) - Exercise/Conversion
Stock Option
2021-03-11−7,591→ 0 totalExercise: $16.60From: 2013-08-02Exp: 2022-08-02→ Common Stock (7,591 underlying) - Exercise/Conversion
Stock Option
2021-03-11−9,500→ 0 totalExercise: $29.39From: 2014-03-29Exp: 2023-03-29→ Common Stock (9,500 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.10, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.